Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,545.60
34.8 (1.39%)
BSENSE

Dec 05

BSE+NSE Vol: 1.62 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
1.39%
0.59%
1W
-0.93%
-0.06%
1M
-4.25%
2.3%
YTD
13.04%
10.75%
1Y
6.9%
5.98%
3Y
89.71%
40.03%
5Y
64.02%
97.51%
10Y
54.99%
236.5%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.11%
0%
-8.11%
6 Months
-26.56%
0%
-26.56%
1 Year
6.9%
0%
6.9%
2 Years
50.48%
2.53%
53.01%
3 Years
89.71%
5.67%
95.38%
4 Years
47.06%
7.79%
54.85%
5 Years
64.02%
10.38%
74.4%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-4.29%
4
Quartile
quartile-4
Jun-Sep
-21.5%
1
Quartile
quartile-1
Mar-Jun
17.63%
2
Quartile
quartile-2
YTD
8.64%
3
Quartile
quartile-3
2024
18.63%
2
Quartile
quartile-2
2023
43.94%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-4.29%
4
Quartile
quartile-4
Jun-Sep
-21.5%
2
Quartile
quartile-2
Mar-Jun
17.63%
1
Quartile
quartile-1
YTD
8.64%
3
Quartile
quartile-3
2024
18.63%
2
Quartile
quartile-2
2023
43.94%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.29%
4
Quartile
quartile-4
Jun-Sep
-21.5%
2
Quartile
quartile-2
Mar-Jun
17.63%
2
Quartile
quartile-2
YTD
8.64%
3
Quartile
quartile-3
2024
18.63%
3
Quartile
quartile-3
2023
43.94%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available